Patent · US Active

Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents

US9381260B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 27, 2012
Grant dateJul 5, 2016
Priority date—
Expiry dateJun 27, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to Hypoxia Inducible Factor-1 pathway inhibitors and uses as anticancer and imaging agents. In certain embodiments, the disclosure contemplates compounds and pharmaceutical compositions disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.